new
insight
studi
viru
host
biolog
context
viral
infect
made
possibl
develop
model
system
faith
recapitul
vivo
viral
life
cycl
standard
tissu
cultur
model
lack
critic
emerg
properti
driven
cellular
organ
vivolik
function
wherea
anim
model
suffer
limit
suscept
relev
human
virus
make
difficult
perform
detail
molecular
manipul
analysi
tissu
engin
techniqu
may
enabl
virologist
creat
infect
model
combin
facil
manipul
readout
tissu
cultur
virusrelev
complex
anim
model
review
state
art
tissu
engin
describ
tissu
engin
techniqu
may
allevi
common
shortcom
exist
model
viral
infect
particular
emphasi
hepatotrop
virus
discuss
possibl
futur
applic
tissu
engin
virolog
includ
current
challeng
potenti
solut
difficult
find
reason
virologist
fail
bacteriologist
success
sever
handicap
difficulti
connect
cultiv
give
virologist
practic
method
isol
studi
virus
reliev
handicap
burden
birth
scienc
place
first
time
even
foot
microb
hunter
sven
gard
nobel
prize
present
speech
virus
oblig
intracellular
pathogen
thu
surpris
field
virolog
continu
advanc
dramat
heel
cell
cultur
technolog
accur
recapitul
viral
infect
laboratori
set
critic
dissect
virushost
interact
ultim
identif
potenti
therapeut
target
subsequ
drug
develop
definit
condit
cell
maintain
cultur
pioneer
late
nineteenth
earli
twentieth
centuri
enabl
initi
vitro
observ
attenu
virus
anim
tissu
cultur
ender
et
al
demonstr
abil
grow
poliomyel
viru
nonneuron
human
embryon
tissu
award
nobel
prize
physiolog
medicin
subsequ
isol
serial
propag
first
human
cell
linehela
cellswhich
shown
suscept
poliomyel
viru
virus
provid
robust
conveni
platform
largescal
viru
amplif
sinc
cell
cultur
model
produc
wealth
knowledg
regard
mechan
infect
still
constitut
primari
platform
viral
propag
pathogenesi
studi
despit
advanc
standard
monolay
suspens
cultur
though
access
well
character
amen
largescal
experiment
adequ
recapitul
complex
live
organ
vivo
cell
integr
higherord
structur
receiv
biochem
mechan
cue
via
interact
extracellular
matrix
ecm
solubl
signal
cell
contribut
compon
cell
state
pleiotrop
may
often
impact
cell
suscept
respons
viral
infect
research
aim
cultur
newli
discov
virus
pinpoint
cellular
factor
impact
cours
diseas
addit
system
bridg
gap
tradit
monolay
cultur
anim
model
requir
end
tissu
engin
te
may
signific
role
move
virolog
next
era
discoveri
owe
greater
control
variou
orthogon
paramet
cell
system
accur
captur
emerg
tissu
properti
eg
multicellular
architectur
exhibit
alter
viabil
morpholog
differenti
statu
prolifer
capac
gene
express
profil
often
yield
phenotyp
differ
significantli
counterpart
convent
cultur
mainten
tissuespecif
host
factor
innat
immun
function
cell
cycl
statu
polar
close
resembl
analog
cell
vivo
may
better
support
natur
cours
viral
infect
cell
standard
tissu
cultur
gener
viral
titer
persist
characterist
close
resembl
vivo
scenario
see
figur
definit
ecm
nich
physic
chemic
biolog
perspect
synthesi
biomateri
control
properti
across
mani
dimens
establish
microtechnolog
tool
enabl
precis
cellular
organ
te
expand
number
type
model
exhibit
emerg
properti
possibl
independ
select
compon
system
cell
type
matrix
etc
defin
scale
geometri
quantiti
individu
model
even
allow
highthroughput
applic
offer
advantag
laboratori
anim
model
alway
avail
costli
difficult
assay
even
subject
ethic
debat
te
model
provid
fertil
middl
ground
experiment
discuss
detail
along
applic
modern
virolog
specif
respect
hepatotrop
virus
wherea
isol
primari
cell
line
lack
access
nativ
environ
typic
modul
phenotyp
vivo
te
offer
abil
control
interact
cell
type
interest
cell
matrix
compon
solubl
growth
factor
cytokin
well
cell
exposur
physic
forc
defin
context
briefli
review
compon
robust
cultur
rel
eas
maintain
viabil
immort
cell
cell
line
hepatoma
cell
use
engin
epitheli
tissu
human
umbil
vein
endotheli
cell
huvec
often
use
te
vascular
construct
stromal
cell
line
also
use
support
primari
progenitorderiv
cell
te
construct
howev
primari
cell
fulli
differenti
exhibit
higher
level
tissuespecif
function
cell
line
prefer
cell
sourc
exampl
engin
tissu
creat
primari
hepatocyt
neuron
cardiomyocyt
addit
flexibl
choic
materi
solubl
factor
mean
te
use
enabl
phenotyp
mainten
cell
type
hepatocyt
hepat
stellat
cell
neuron
wherea
standard
cell
cultur
platform
final
stemand
progenitorderiv
cell
increasingli
use
te
though
cell
type
challeng
maintain
differenti
state
current
differenti
protocol
often
yield
immatur
cell
type
close
relat
fetal
adult
cell
offer
promis
genet
tractabl
expand
fulli
function
cell
te
strategi
recapitul
development
nich
result
success
earli
exampl
sever
stem
cellderiv
tissu
includ
liver
brain
intestin
heart
vasculatur
numer
effort
expand
combin
tissu
type
underway
biomateri
provid
mechan
support
chemic
cue
cell
te
scaffold
mani
biomateri
studi
choic
biomateri
depend
upon
specif
fabric
tissu
natur
materi
often
contain
endogen
domain
encourag
cell
attach
prolifer
stimul
strong
immun
respons
upon
implant
make
promis
transplant
applic
natur
te
materi
includ
fibrin
promot
angiogenesi
vascular
integr
collagen
ubiquit
compon
ecm
numer
integrinbind
motif
hyaluron
acid
algin
basement
membranemimick
matrigel
howev
natur
biomateri
less
well
character
less
amen
synthet
materi
engin
modif
allevi
shortcom
wide
varieti
synthet
polymer
materi
develop
te
applic
includ
us
food
drug
administr
fda
approv
materi
poli
lacticcoglycol
acid
plga
base
poli
ethylen
glycol
peg
base
materi
well
newer
class
polym
exhibit
better
antifoul
properti
modular
stimulu
respons
materi
mechan
gelform
properti
tune
wide
rang
typic
design
provid
biolog
inert
background
upon
bioactiv
motif
rgd
ad
way
combin
bioactiv
properti
natur
materi
modular
control
synthet
materi
tissu
engin
gener
mani
exampl
hybrid
materi
contain
natur
synthet
compon
often
provid
orthogon
control
function
gelatin
methacryl
synthes
collagen
photocrosslink
biomateri
use
bioprint
stereolithographi
maintain
base
materi
cytocompat
properti
numer
hyaluron
acid
deriv
engin
exhibit
photoactivat
constitut
crosslink
allow
display
tether
peptid
protein
differ
strategi
martino
et
al
recent
develop
pegfibrin
hybrid
minim
fibrinogen
fragment
graft
onto
tunabl
peg
backbon
impart
fibrin
proangiogen
growth
factorbind
properti
addit
cell
interest
scaffold
materi
te
model
commonli
incorpor
growth
factor
modul
cell
function
vegf
vascular
endotheli
growth
factor
pdgf
plateletderiv
growth
factor
commonli
util
encourag
angiogenesi
matur
engin
vessel
skelet
muscl
bone
morphogen
protein
use
encourag
bone
tissu
growth
ngf
nerv
growth
factor
use
encourag
neuron
growth
unlik
standard
monolay
cultur
transport
util
growth
factor
passiv
sequestr
protein
bind
partner
chemic
induc
tether
growth
factor
lead
gradient
format
distinct
zone
engin
tissu
better
recapitul
heterogen
organ
microenviron
stimuli
also
produc
spatial
distinct
signal
effect
engin
tissu
oxygen
avail
dens
pack
tissu
vari
distanc
perfus
channel
oxygen
tension
significantli
affect
numer
cellular
pathway
similarli
shear
stress
induc
fluid
flow
affect
endotheli
phenotyp
affect
mani
epitheli
cell
shear
protect
vivo
gradient
modul
vari
vessel
densiti
perfus
rate
construct
flow
provid
physiolog
microenviron
platform
continu
sampl
engin
construct
vivo
tissu
microarchitectur
intim
link
function
therefor
control
tissu
architectur
explor
engin
construct
abil
pattern
cell
use
engin
techniqu
exploit
engin
cultur
exampl
cell
shape
examin
spatial
segreg
cocultur
differ
cell
type
gener
microcontact
print
adhes
protein
cellular
pattern
also
extend
te
order
control
cell
spread
movement
spatial
organ
group
cell
control
product
vascular
network
mani
techniqu
use
accomplish
goal
photolithograph
porositygener
techniqu
modifi
overal
scaffold
structur
orthogon
chemic
approach
use
pattern
protein
mechan
variat
construct
dna
shapetempl
approach
also
use
hierarch
assembl
small
cellladen
build
block
larger
multicompon
structur
recent
improv
print
biolog
materi
also
enabl
direct
deposit
cell
matrix
defin
configur
te
model
potenti
bridg
gap
viral
infect
standard
cell
cultur
may
lack
higherord
tissu
function
infect
anim
model
less
experiment
genet
tractabl
may
make
difficult
isol
respons
interest
review
benefit
te
specif
studi
viral
infect
wherea
standard
cell
cultur
model
viral
infect
limit
singl
cell
type
viral
infect
vivo
involv
multipl
cell
type
te
approach
potenti
captur
cellular
divers
use
liver
exampl
demonstr
depend
hepatocyt
state
support
cell
type
includ
endothelium
fibroblast
kupffer
cell
interact
import
hepat
c
viru
hcv
infect
virion
bind
liver
sinusoid
endotheli
cell
lsec
receptor
result
transcript
chang
directli
transinfect
indirectli
lsec
cytokin
product
affect
hcv
infect
hepatocyt
kupffer
cell
activ
hcv
also
modul
viral
progress
incorpor
two
cell
type
livermimick
microenviron
could
constitut
relev
cellular
milieu
understand
hcv
infect
vitro
hepat
b
viru
hbv
similarli
modul
innat
immun
pathway
liver
nonparenchym
cell
affect
hepatocyt
way
engin
cocultur
system
might
captur
beyond
captur
relev
cellcel
interact
te
offer
avenu
studi
dynam
process
hostpathogen
interact
infectionrelev
phenotyp
endotheli
barrier
permeabil
immun
cell
traffick
incorpor
engin
system
exampl
dengu
viru
denv
infect
endotheli
cell
lead
inflamm
increas
permeabl
progress
septic
shock
upon
immun
cell
recruit
infect
endotheli
cell
model
phenomenon
could
help
predict
treat
vascular
complic
dynam
measur
enabl
te
extend
multicompon
tissu
well
multipl
tissu
compart
fabric
spatial
control
manner
microscal
mesoscal
microstructur
materi
cell
encapsul
assembl
microtissu
contain
distinct
cell
popul
increas
control
materi
chemistri
process
also
allow
engin
interfac
smoothli
connect
differ
engin
tissu
type
may
import
studi
virus
affect
multipl
tissu
compart
exampl
multistag
infect
cycl
herp
simplex
viru
hsv
difficult
model
standard
cell
cultur
creat
spatial
defin
mucos
neural
compart
manner
amen
timelaps
imag
analysi
viral
latenc
reactiv
could
potenti
studi
directli
even
within
tissu
spatial
variat
cellular
phenotyp
affect
viral
infect
cell
type
compartment
posit
afford
te
techniqu
may
also
use
understand
influenza
infect
exampl
engin
respiratori
tract
could
potenti
use
conclus
determin
sialic
acidlink
receptor
specif
avian
human
virus
effect
import
airway
compon
respiratori
mucu
layer
could
studi
experiment
facil
system
effect
detail
adequ
captur
anim
model
infect
howev
wherea
intravit
imag
techniqu
improv
capabl
access
realtim
monitor
cellular
molecular
paramet
deeper
organ
difficult
genet
manipul
system
requir
timeconsum
mous
engin
breed
te
coupl
abil
gener
relev
tissu
complex
abil
easili
manipul
input
cell
captur
biolog
virolog
readout
cell
te
construct
easili
access
growth
factor
cytokin
also
manipul
genet
lentivir
transduct
rna
interfer
either
prior
encapsul
situ
engin
tissu
tether
trap
virus
nucleic
acid
scaffold
materi
manipul
also
spatial
control
target
select
subset
cell
combin
report
easili
introduc
encapsul
cell
numer
standard
imag
modal
avail
analyz
te
construct
includ
fluoresc
tomographi
multiphoton
fluoresc
compat
thick
engin
tissu
magnet
reson
electron
microscopi
mani
approach
use
real
time
provid
dynam
pictur
viral
infect
engin
tissu
although
applic
te
viral
model
still
infanc
sever
exist
exampl
pathogen
infect
engin
tissu
pertain
liver
cover
detail
outsid
liver
te
techniqu
also
use
creat
vitro
model
infect
captur
latent
neuron
infect
reactiv
model
latent
infect
combin
neuron
dermal
layer
resid
next
epiderm
layer
airwat
interfac
latent
hsv
dna
reactiv
upon
uv
exposur
provid
vitro
reactiv
model
complement
anim
studi
hsv
also
studi
context
oncolyt
viru
therapi
te
tumor
model
viral
infect
spread
depend
upon
ecm
degrad
brain
tumor
melanoma
model
dynam
cultur
system
support
microorgan
growth
well
commens
bacterium
modul
epitheli
barrier
integr
te
microfluid
devic
although
initi
effort
incorpor
virus
could
adapt
studi
enteroviru
infect
relev
intestin
model
recent
effort
engin
vitro
bone
marrow
analog
may
also
aid
studi
viral
infect
appropri
te
system
mimick
bone
marrow
microenviron
shown
promot
hematopoiet
stem
progenitor
cell
differenti
even
result
b
lymphocyt
differenti
influenzaspecif
antibodi
format
upon
inocul
viru
effort
highlight
potenti
te
provid
relev
viral
model
system
futur
hepatotrop
virus
global
distribut
caus
acut
eg
hepat
viru
hav
hepat
e
viru
hev
chronic
eg
hbv
hcv
infect
lead
liver
fibrosi
cirrhosi
hepatocellular
carcinoma
ultim
endstag
liver
diseas
requir
liver
transplant
although
function
hav
hbv
recent
hev
vaccin
avail
along
directact
antivir
target
hbv
hcv
pathogen
remain
preval
human
popul
furthermor
continu
challeng
studi
laboratori
set
due
pauciti
robust
model
system
mimic
clinic
aspect
diseas
attempt
cultur
virus
vitro
vivo
limit
restrict
host
rang
hepatotrop
although
hev
found
variou
speci
addit
human
review
hav
infect
human
nonhuman
primat
speci
human
chimpanze
tree
shrew
tupaia
belangeri
natur
suscept
hcv
hbv
review
requir
liverenrich
factor
microrna
hcv
transcript
factor
eg
liver
enrich
hbv
restrict
cell
type
permit
viral
replic
absenc
cell
cultureadapt
mutat
slow
viral
replic
protein
synthesi
kinet
also
remain
issuein
case
wildtyp
hav
antigen
accumul
particl
product
take
week
although
effici
cell
cultur
system
establish
hcv
isol
genotyp
gt
viru
japanes
patient
fulmin
hepat
c
viru
genet
divers
includ
six
major
genotyp
numer
subtyp
differ
geograph
distribut
respons
antivir
therapi
diseas
associ
review
current
studi
genotypespecif
phenotyp
restrict
replicon
hcv
pseudoparticl
intergenotyp
recombin
virus
hev
cell
cultur
system
exist
two
zoonot
genotyp
four
identifi
date
infect
human
still
effici
hev
growth
cell
cultur
poor
wherea
cdna
clone
hev
strain
gener
shown
infecti
either
nonhuman
primat
pig
vitro
studi
limit
due
lack
viru
spread
cultur
cell
similarli
hbv
hepatoma
cell
replic
assembl
viru
eg
identifi
cell
permit
hbv
entri
without
addit
manipul
research
therefor
resort
system
featur
integr
hbv
genom
deliveri
hbv
dna
cell
via
transfect
exist
model
hepatotrop
viral
infect
reli
predominantli
upon
human
hepatomaor
hepatocellular
carcinomaderiv
cell
line
aberr
prolif
potenti
polar
line
combin
dysfunct
drug
metabol
innat
immun
axi
obscur
import
biolog
make
critic
studi
viral
infect
authent
host
cell
primari
human
hepatocyt
addit
viral
host
genet
profound
impact
outcom
infect
influenc
polymorph
locu
spontan
clearanc
hcv
respons
treatment
highli
vari
success
achiev
infect
primari
hepatocyt
differ
human
donor
thu
great
interest
establish
vitro
vivo
platform
virus
pangenotyp
permiss
particularli
featur
natur
target
cell
viru
reflect
genet
divers
infect
popul
eg
primari
human
hepatocyt
pluripot
stem
cellderiv
hepatocytelik
cell
manipul
immort
cell
toward
polar
differenti
state
result
permiss
system
hepatotrop
viral
infect
yield
uniqu
insight
viral
entri
mechan
earli
evid
product
hcv
infect
cultur
came
use
human
hepatocellular
carcinomaderiv
line
cultur
radialflow
bioreactor
recent
ali
cowork
demonstr
hcv
replic
increas
immort
primari
hepatocyt
cultur
thermorevers
gelatin
polym
tgp
system
viral
particl
product
achiev
upon
challeng
hcv
cell
cultur
hollow
fiber
system
like
tgp
system
hollow
fiber
reactor
smaller
scale
radialflow
bioreactor
allow
easi
access
medium
cell
virolog
assess
standard
cell
cultur
model
heparg
cell
also
shown
permiss
serumderiv
hcv
prolifer
stage
cell
fulli
differenti
abl
replic
viru
produc
infecti
particl
indic
properti
immatur
matur
hepatocyt
may
benefici
cultur
hcv
vitro
addit
polar
model
includ
cell
ectop
express
receptor
viru
cell
expos
dimethyl
sulfoxid
dmso
matrigel
rotat
wall
vessel
shown
permiss
hcv
system
demonstr
uniqu
viral
phenotyp
includ
infecti
particl
product
dicistron
hcv
genom
shift
viral
particl
densiti
compar
viru
suggest
assembl
associ
host
protein
andor
lipid
may
alter
hcv
result
also
extend
engin
tissu
hcvpermiss
cell
line
notabl
addit
human
serum
medium
sever
system
benefici
impact
promot
increas
extracellular
hcv
rna
product
human
adult
hepatocyt
rapid
viral
penetr
follow
consist
detect
hcv
rna
inocul
heparg
cell
human
serumderiv
hcv
steenbergen
colleagu
also
report
growth
arrest
increas
express
albumin
lipid
metabolismrel
gene
cellcel
contact
protein
well
hcv
receptor
cell
expos
human
serum
cell
produc
highertit
lowerdens
hcv
suggest
serum
factor
impact
cellular
viral
phenotyp
cell
context
also
recent
consid
goal
increas
viral
yield
hev
infect
system
berto
colleagu
demonstr
detect
hev
rna
supernat
cell
cultiv
rotat
wall
vessel
cultur
inocul
parallel
et
al
also
demonstr
hev
rna
supernat
matrigelembed
heparg
cell
bipot
human
porcin
line
respect
differenti
biliari
hepatocytelik
cell
cultur
murin
embryon
fibroblast
direct
comparison
rna
level
produc
system
produc
primari
hepatocyt
cell
line
standard
cultur
challeng
given
differ
sourc
titer
quantiti
inoculum
use
howev
system
may
abrog
requir
hightit
inocul
launch
infect
may
enabl
uniqu
insight
infect
pathwaysparticularli
entri
egress
exampl
vectori
entri
releas
hav
shown
differ
enterocytederiv
polar
cell
porou
membran
support
apic
subclon
cell
basolater
consist
expect
rout
exposur
hav
transmiss
hcv
entri
process
involv
two
tight
junction
protein
occludin
highlight
import
polar
cell
model
defin
precis
entri
mechan
express
organ
dynam
receptor
alter
upon
polar
sever
studi
note
reduc
suscept
infect
follow
polar
suggest
cell
junction
also
act
physic
barrier
disrupt
tight
junction
may
promot
viral
transmiss
use
cellular
protein
local
region
may
facilit
cellcel
spread
hbv
infect
also
depend
cell
differenti
statu
cell
normal
support
hbv
replic
viru
releas
follow
transfect
hbv
dna
treat
cell
dmso
render
permiss
hbv
entri
similarli
differenti
state
heparg
cellsmedi
dmso
corticoid
treatmentcorrel
hbv
suscept
express
bile
acid
pump
ntcp
sodium
taurochol
cotransport
polypeptid
newli
identifi
receptor
hbvincreas
upon
differenti
heparg
cell
decreas
primari
tupaia
hepatocyt
plate
interestingli
dmso
treatment
either
cell
overexpress
ntcp
robustli
increas
infect
effici
hbvpermiss
cell
collect
observ
link
cellular
differenti
entri
factor
express
viral
suscept
hbv
gene
express
replic
also
link
cellular
differenti
statu
induc
cultur
cell
ecm
treat
dmso
dexamethason
like
due
increas
express
requir
host
transcript
factor
regul
control
hbv
transcript
machineri
te
techniqu
modul
cell
polar
differenti
statu
control
cellcel
cellmatrix
interact
solubl
signal
modul
strongli
affect
viral
infect
model
although
differenti
polar
cell
yield
accur
insight
entri
event
host
respons
infect
still
differ
immort
cell
compar
authent
host
cell
due
abnorm
prolifer
dysregul
gene
express
aberr
signal
thu
primari
cell
model
may
use
certain
aspect
hostpathogen
biolog
applic
te
concept
primari
human
hepatocyt
induc
pluripot
stem
cell
ipsc
deriv
cell
made
model
system
tractabl
enabl
vitro
interrog
viral
infect
across
cell
differ
genet
background
although
primari
hepatocyt
princip
target
cell
hepatotrop
virus
thu
physiolog
relev
model
system
infect
cell
vitro
challeng
dissoci
nativ
hepat
microenviron
primari
hepatocyt
lose
polyhedr
morpholog
exhibit
declin
liverspecif
function
determin
albumin
secret
cytochrom
enzymat
activ
becom
less
suscept
viral
infect
multipl
group
challeng
primari
hepatocyt
human
fetal
adult
chimpanze
nonhuman
primat
tupaia
tissu
culturederiv
viru
sera
infect
hcv
hev
hbv
patient
result
suggest
inocul
high
viral
load
necessari
suffici
amplif
typic
low
level
fluctuat
similar
induct
differenti
state
immort
cell
mainten
state
primari
hepatocyt
vitro
critic
initi
suscept
infect
effici
viral
replic
earli
report
note
increas
yield
durat
hbv
infect
presenc
dmso
peg
recent
group
employ
nonparenchym
cell
promot
hepatocyt
function
subsequ
viral
infect
vitro
ldlr
lowdens
lipoprotein
receptor
egfr
epiderm
growth
factor
receptor
two
host
cofactor
hcv
entri
highli
express
hepatocyt
cultur
lsec
singl
layer
collagen
spheroid
form
matrigel
spheric
hepatocyt
mass
initi
cultur
presenc
preattach
stellat
cell
effici
replic
hcv
clone
similarli
longterm
cultur
primari
human
fetal
hepatocyt
develop
plate
hepat
cell
mixtur
low
densiti
allow
outgrowth
nonparenchym
cell
format
hepat
island
subsequ
cultur
dmsocontain
condit
maintain
characterist
hepatocyt
featur
cultur
suscept
hbv
infect
week
cultur
engin
tissu
huvec
use
modul
fetal
hepatocyt
phenotyp
permit
hcv
replic
ad
microscal
architectur
concept
cocultur
system
ploss
et
al
gener
miniatur
hepatocyt
island
optim
dimens
surround
support
murin
embryon
fibroblast
cell
term
micropattern
cocultur
mpcc
unlik
collagen
gel
sandwich
matrigel
substratum
random
cocultur
mpcc
abl
sustain
infect
luciferaseexpress
hcvcc
infect
frequenc
system
low
hcvcc
plasma
sera
infect
patient
author
demonstr
potenti
applic
model
physiolog
system
preclin
screen
antivir
therapeut
beyond
hcv
model
also
support
infect
malaria
hbv
unpublish
data
toward
recapitul
complet
tissu
architectur
human
adult
ex
vivo
liver
slice
method
recent
adapt
virolog
common
challeng
system
includ
poor
viabil
inher
variabl
howev
lagay
et
al
demonstr
product
infect
chimer
virus
well
primari
isol
cultur
remain
viabl
day
theori
primari
human
hepatocyt
provid
opportun
correl
host
genotyp
viral
phenotyp
control
experiment
condit
practic
difficult
achiev
statist
signific
given
limit
number
donor
avail
inabl
prescreen
select
cell
patient
particular
genotyp
interest
altern
pluripot
stem
cell
capac
infinit
selfrenew
genet
alter
pluripot
stage
differenti
hepatocytelik
cell
enabl
introduct
desir
host
phenotyp
parallel
product
isogen
control
importantli
human
embryon
stem
cell
hesc
ipscderiv
hepatocytelik
cell
support
complet
hcv
life
cycl
evidenc
entri
replic
hcvpseudotyp
viru
subgenom
replicon
assay
respect
challeng
hcvcc
patient
sera
hcvser
wherea
cell
permiss
hcvser
addit
short
hairpin
rnamedi
knockdown
cyclophilin
render
cell
resist
hcv
provid
proof
concept
use
genet
manipul
cell
interrog
hostpathogen
interact
still
human
hepatocyt
deriv
pluripot
stem
cell
directli
fibroblast
via
transdifferenti
still
function
immatur
exhibit
differ
transcript
profil
primari
adult
human
hepatocyt
recent
approach
matur
cell
use
chemic
genet
combin
approach
yield
adultlik
phenotyp
import
ensur
hostpathogen
interact
explor
system
indic
matur
respons
infect
restrict
speci
tropism
hepatotrop
virus
led
develop
transgen
human
mous
model
eg
upa
scid
fah
launch
infect
hbv
hcv
vivo
review
although
chimer
human
liver
mous
modelsin
genet
injuri
mous
hepatocyt
permit
repopul
expans
transplant
human
hepatocytesallow
complet
entir
viral
life
cycl
instrument
establish
rodent
model
hbv
hcv
restrict
low
breed
effici
high
mortal
need
consist
robust
engraft
human
hepatocyt
achiev
hcv
viremia
along
variabl
chimer
led
difficulti
costeffect
gener
larg
cohort
mice
viral
challeng
attempt
allevi
issu
effort
gener
addit
mous
model
focus
supplement
critic
nonhomolog
host
factor
suppress
innat
immun
viral
adapt
altern
implant
te
model
featur
human
cell
immunodefici
mice
stabil
cell
phenotyp
minim
engraft
variabl
serv
platform
assess
drug
metabol
toxic
vivo
work
extend
engin
tissu
model
hcv
malaria
hbv
infect
primari
hepatocyt
way
creat
ectop
human
liver
permiss
infect
smallanim
model
ectop
tissu
may
also
provid
altern
liver
injurybas
mous
model
allow
research
circumnavig
host
barrier
infect
vivo
date
identif
te
model
system
promot
desir
cellular
virolog
phenotyp
larg
empir
rapid
optim
model
benefit
platform
allow
systemat
perturb
microenviron
may
result
prolong
cellular
viabil
express
host
protein
critic
viral
propag
toward
goal
ecm
array
employ
determin
optim
substrat
mainten
liverspecif
function
rat
hepatocyt
murin
embryon
stem
cell
differenti
test
combinatori
effect
ecm
solubl
factor
cell
fate
highthroughput
platform
also
recent
describ
construct
system
hold
potenti
drug
toxic
screen
cellecm
interact
studi
investig
cellular
phenotyp
depend
cellular
local
within
tissu
similar
vivo
case
system
provid
method
identif
microenvironment
cue
yield
desir
cellular
properti
use
concert
genomeedit
tool
includ
crisprca
cluster
regularli
interspac
short
palindrom
repeatcrisprassoci
talen
transcript
activatorlik
effector
nucleas
approach
enabl
precis
control
cellautonom
aspect
well
combin
te
model
system
ipsc
technolog
research
principl
gener
person
model
viral
infect
follow
clinic
data
studi
host
factor
signific
clinic
correl
identifi
human
genet
studi
tissu
engin
exercis
great
level
control
type
posit
cell
scaffold
materi
use
te
studi
viral
infect
expand
integr
dynam
report
cellular
function
infect
establish
platform
select
analysi
cellular
subset
within
engin
tissu
fluoresc
report
infect
monitor
engin
modifi
either
viru
host
protein
use
parallel
report
host
pathway
interferon
regulatori
factor
nuclear
factor
track
infect
spread
respons
real
time
unpreced
resolut
cellular
respons
infect
also
modifi
local
microenviron
ecm
remodel
local
cytokin
releas
track
real
time
tether
report
proteas
activ
biomolecul
accumul
engin
tissu
integr
viral
cell
state
report
te
construct
may
also
aid
select
subpopul
interest
analysi
transcriptom
proteom
level
laser
captur
microdissect
use
select
isol
infect
cell
engin
tissu
newli
develop
photouncag
approach
use
isol
rna
specif
cell
tissu
addit
abil
select
degrad
certain
scaffold
hydrogel
light
offer
orthogon
approach
access
specif
cell
within
engin
tissu
extend
te
develop
organonachip
system
enabl
greater
understand
multiorgan
interact
viral
infect
advanc
microfluid
onchip
cell
cultur
assembl
microscal
engin
tissu
segment
could
enabl
multiorgan
circuit
consist
cell
connect
function
organ
modul
accur
recapitul
vivo
biochem
metabol
genet
activ
pertin
develop
viral
model
multiorgan
system
could
includ
engin
lymphoid
compon
serv
dynam
reservoir
circul
immun
cell
constitut
part
host
respons
virus
interconnect
organ
modul
also
effici
endotheli
enabl
studi
endotheli
respons
either
upon
primari
infect
secondari
system
cytokin
releas
exist
multipl
organ
modul
also
offer
potenti
predict
offtarget
effect
new
propos
antivir
therapi
matrix
remodel
cell
migrat
chemic
gradient
mechan
forc
laminar
shear
stress
impos
blood
flow
phasic
stress
produc
breath
repres
dynam
aspect
live
system
chemic
gradient
mechan
forc
modul
cell
function
impact
cours
infect
microfluid
devic
repres
versatil
miniatur
automat
platform
gener
gradient
forc
vitro
use
microfluid
virolog
infanc
exampl
illustr
potenti
viral
infect
dynam
studi
viral
quantif
diagnost
imag
singleparticl
assay
well
screenbas
approach
identifi
novel
hostpathogen
interact
adopt
te
approach
model
viral
infect
depend
make
tissu
engin
platform
robust
access
captur
much
relev
biolog
possibl
review
major
remain
challeng
along
path
although
standard
tissu
cultur
approach
often
lack
key
host
function
still
wide
use
experiment
simplic
robust
tissu
engin
similarli
focu
standard
make
te
access
studi
viral
infect
materi
side
numer
approach
reduc
te
scaffold
variabl
first
largebatch
synthesi
modif
scaffold
materi
reduc
variabl
chemic
modif
percentag
synthesi
run
problem
also
mitig
use
newli
develop
higheffici
orthogon
chemic
reaction
scaffold
modif
crosslink
use
control
polymer
reaction
synthet
materi
standard
steril
asept
techniqu
te
scaffold
manipul
also
prevent
contamin
sometim
occur
complex
cultur
format
toward
end
lesson
learn
exist
standard
te
platform
mpcc
use
industri
scale
screen
drug
human
liver
toxic
aggrewel
plate
reliabl
produc
defineds
cellular
aggreg
stem
cell
cultur
te
recent
scalabl
platform
pluripot
stem
cell
cultur
also
report
use
commerci
avail
thermorespons
materi
evidenc
exampl
focus
simplic
structur
materi
choic
process
aid
standard
te
format
unlik
standard
monolay
cell
cultur
cell
te
construct
subject
nutrient
transport
constraint
due
natur
cultur
format
imped
transport
materi
small
pore
size
gener
cell
te
construct
must
within
perfus
channel
receiv
adequ
level
nutrient
strategi
vascular
te
extens
cover
recent
review
eg
use
te
model
studi
viral
infect
vascular
requir
may
even
acut
virion
must
abl
access
host
cell
within
construct
virion
may
travers
smallpor
peg
hydrogel
host
cell
process
ineffici
across
long
distanc
addit
virus
util
entri
receptor
specif
polar
appropri
cell
posit
polar
must
maintain
te
construct
facilit
viral
entri
transport
relev
viral
infect
even
outsid
virion
access
oxygen
tension
gradient
gener
celldens
te
construct
affect
viral
replic
hypoxiainduc
factor
depend
mechan
sever
method
exist
provid
adequ
transport
within
te
platform
either
prefabr
vascular
channel
use
sacrifici
materi
direct
cell
seed
via
microengin
bioprint
stimul
selforgan
endotheli
vascular
network
vitro
model
viral
infect
new
paralleliz
bioprint
approach
favor
combin
reproduc
channel
format
scalabl
adequ
power
studi
print
multipl
materi
cell
type
defin
posit
enabl
pattern
vascular
network
format
next
viral
permiss
parenchym
tissu
compon
conjunct
adequ
vascular
access
tissu
compart
continu
develop
orthogon
fluoresc
secret
report
viral
cell
state
enabl
multiplex
realtim
analysi
viral
infect
te
construct
although
cell
line
gener
amen
manipul
develop
physiolog
relev
viral
model
requir
use
fragil
primari
stemor
progenitorderiv
cell
cellcel
signal
densiti
inher
cultur
system
promot
phenotyp
mainten
function
primari
progenitor
cell
previous
develop
protocol
cell
mainten
direct
differenti
progenitor
cell
may
directli
translat
te
system
protocol
perform
prior
cell
isol
te
scaffold
incorpor
isol
nativ
microenviron
often
diminish
tissuespecif
function
differenti
cell
multicompart
te
model
optim
cultur
medium
formul
signal
may
vari
compart
compart
sever
approach
may
use
circumv
problem
optim
protocol
longterm
cultur
format
allow
atraumat
cell
harvest
cultur
step
elimin
altogeth
te
differenti
stemderiv
cell
develop
protocol
situ
direct
differenti
progenitor
use
aid
inher
advantag
differenti
lineag
vast
choic
cell
fateinstruct
scaffold
materi
increas
control
biomolecul
present
valenc
te
construct
new
approach
highthroughput
array
cultur
format
addit
precis
control
mix
microfluid
system
may
allow
spatial
gradient
nutrient
composit
control
differenti
statu
phenotyp
mainten
enabl
cross
talk
organ
modul
prevent
offtarget
effect
cultur
medium
addit
studi
virolog
depend
adequ
model
system
accur
captur
variou
stage
viral
infect
entri
replic
egress
compar
standard
cell
cultur
techniqu
one
end
anim
model
te
potenti
recapitul
relev
higherord
interact
preserv
abil
readili
manipul
distinct
compon
system
continu
advanc
te
readili
allow
precis
posit
cell
matrix
solubl
factor
interact
compon
way
captur
emerg
properti
import
viral
infect
exampl
te
approach
enabl
studi
viral
infect
spread
multiorgan
model
elucid
hostpathogen
interact
authent
host
cell
develop
mediumand
highthroughput
analys
viral
replic
physiolog
context
howard
hugh
medic
investig
apolog
whose
work
could
cite
due
space
restrict
tissu
engin
te
approach
recapitul
complex
vivo
environ
schemat
overview
tissu
engin
approach
standard
tissu
cultur
consist
monocultur
monolay
tissu
vivo
made
variou
cell
type
organ
specif
structur
te
approach
aim
model
emerg
properti
architectur
vivo
environ
use
combin
relev
cell
type
extracellular
matrix
protein
mimic
solubl
signal
eg
cytokin
organ
specif
pattern
use
engin
tool
promot
cellular
health
vitro
function
upon
implant
vivo
eg
vascular
te
model
replic
aspect
vivo
environ
may
enhanc
viru
permiss
result
authent
hostviru
interact
te
model
assembl
induc
pluripot
stem
cell
ipsc
deriv
cell
could
also
give
rise
person
model
defin
manipul
host
genet
b
chart
compar
te
approach
vitro
vivo
platform
te
model
bridg
simplic
tissu
cultur
complet
anim
model
maintain
capac
easi
manipul
interrog
cellular
viral
input
